Market Leadership Royal Paper is a leading privately-owned tissue manufacturer in the US with extensive experience and advanced machinery, positioning it as a key player in both retail and commercial tissue markets, which presents opportunities for high-volume supply partnerships.

Sustainable Focus As the top manufacturer of 100% Grade A recycled paper in the US, Royal Paper emphasizes its commitment to sustainability, creating a strong appeal to environmentally conscious brands seeking eco-friendly product sourcing.

Recent Asset Acquisition Following its acquisition by Envoy Solutions and the sale of assets to Sofidel Group, Royal Paper demonstrates ongoing consolidation and opportunities for strategic collaborations or supply chain integrations with well-established industry players.

Financial Potential With revenues ranging from $100M to $250M, Royal Paper represents a significant market opportunity for suppliers and partners aiming to serve a substantial customer base in the tissue manufacturing sector.

Industry Evolution Recent bankruptcy and asset sales indicate ongoing industry restructuring, which could open avenues for innovative partnerships, offering tailored solutions during this period of change.